The circle of strife
Monday, March 31st, 2008Wine sold in the EU ( and probably elsewhere ) contain high levels of pesticides.
From the AP via Google …
Pesticide Action Network Europe, an umbrella organisation for concerned groups in Austria, France and Germany, said it had “uncovered substantial evidence” of contamination by studying 40 sample bottles of wines.
The wines were of Australian, Austrian, Chilean, French, Italian, German, Portuguese and South African and included six wines produced through organic farming.
The non-organic bottles of wine contained on average traces of four pesticides; one revealed 10 different pesticides.
The group’s analysis found 24 specific pesticide contaminants, including five it said were classified by the European Union as being carcinogenic, mutagenic, reprotoxic or endocrine disrupting.
Of the six organic wines tested, only one contained traces of pesticides, at low levels and probably because of such chemicals in neighbouring plots.
“Many grape farmers are abandoning traditional methods of pest control in favour of using hazardous synthetic pesticides,”
Strong link between Pesticides and Parkinson’s
From the Beeb …
There is strong evidence that exposure to pesticides significantly increases the risk of Parkinson’s disease, experts believe.
The US researchers found those exposed to pesticides had a 1.6 times higher risk after studying 600 people.
Experts said it was now highly likely pesticides played a key role - albeit in combination with other factors.
The disorder, which normally develops later in life and can affect movement and talking, is also influenced by genetic factors.
Several gene defects have been identified, but these are thought to be rare and only account for a small proportion of the 120,000 people affected by the disease in the UK.
The US team, which involved scientists from Duke University, Miami University and the Udall Parkinson’s Disease Research Center of Excellence, quizzed 319 patients about their pesticide use.
The answers were compared to over 200 family members and other controls who did not have the disease.
Related individuals were chosen as they would share many environmental and genetic backgrounds in a bid to isolate the impact of the pesticides.
They found those exposed to pesticides had a 1.6 times greater risk of developing the disease.
Heavy use, classed as over 200 days exposure over a lifetime, carried over double the risk.
And the study also revealed herbicides and insecticides were the pesticides most likely to increase risk.
“What we noticed in our research was that recreational pesticide use in the home and garden was more of a source of exposure than occupational use.”
out a survey of 10,000 patients by the charity had revealed only one in 10 had had long-term exposure to pesticides.
Parkinson’s cured using cloned stem cells.
Also from the Beeb …
Therapeutic cloning has been successfully used to treat Parkinson’s disease in mice
In Parkinson’s disease, nerve cells in the part of the brain that controls muscle movement either die or become impaired.
Normally, these cells produce a vital chemical known as dopamine, which allows smooth, co-ordinated function of the body’s muscles and movement.
In therapeutic cloning, the nucleus of a cell is inserted into an egg with the nucleus removed.
This cell then develops into an embryo from which stem cells can be harvested and used as a treatment.
In this study, stem cells were developed into dopamine-producing neurons the missing nerve cells in Parkinson’s disease.
The mice that received neurons derived from their own clones showed significant signs of improvement.
But when these neurons were grafted into mice that did not genetically match the transplanted cells, the cells did not survive and the mice did not recover.
Scientists are pursuing the use of stem cell therapy for Parkinson’s disease because it would allow the replacement of the dead dopamine-producing nerve cells with new, healthy cells.
This should restore the supply of dopamine within the brain and allow it to work normally again.
Professor Robin Lovell-Badge, an expert in stem cell research at the National Institute of Medical Research, said this was good research which showed using therapeutic cloning could be beneficial.
“There was a very significant level of recovery.
But he added: “They only studied the mice for 11 weeks afterwards, which is not a huge amount of time to see how persistent the repaid would be.”
However, the experts said much more research in both animals and humans was needed before the treatment could be offered to people with Parkinson’s.